sRAGE attenuates angiotensin II-induced cardiomyocyte hypertrophy by inhibiting RAGE-NFκB-NLRP3 activation

被引:0
作者
Soyeon Lim
Myung Eun Lee
Jisu Jeong
Jiye Lee
Soyoung Cho
Miran Seo
Sungha Park
机构
[1] Catholic Kwandong University,Institute for Bio
[2] Yonsei University College of Medicine,Medical Convergence, College of Medicine
[3] Yonsei University College of Medicine,Severance Integrative Research Institute for Cerebral and Cardiovascular Diseases
[4] Yonsei University,Cardiovascular Research Institute
[5] Yonsei University College of Medicine,Graduate Program in Science for Aging and Yonsei Research Institute of Aging Science
[6] Yonsei University,Division of Cardiology, Severance Cardiovascular Hospital
来源
Inflammation Research | 2018年 / 67卷
关键词
RAGE; Soluble RAGE; Cardiac hypertrophy; NLRP3;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:691 / 701
页数:10
相关论文
共 234 条
[1]  
Paradis P(2000)Overexpression of angiotensin II type I receptor in cardiomyocytes induces cardiac hypertrophy and remodeling Proc Natl Acad Sci USA 97 931-936
[2]  
Dali-Youcef N(2007)Telmisartan, an angiotensin II type 1 receptor blocker, inhibits advanced glycation end-product (AGE)-induced monocyte chemoattractant protein-1 expression in mesangial cells through downregulation of receptor for AGEs via peroxisome proliferator-activated receptor-gamma activation J Int Med Res 35 482-489
[3]  
Paradis FW(2009)RAGE signaling in inflammation and arterial aging Front Biosci 14 1403-1413
[4]  
Thibault G(2011)RAGE and cardiovascular disease Front Biosci 16 486-497
[5]  
Nemer M(2011)RAGE regulates autophagy and apoptosis following oxidative injury Autophagy 7 442-444
[6]  
Matsui T(2013)Autophagy plays an essential role in mediating regression of hypertrophy during unloading of the heart Plos One 34 1399-1411
[7]  
Yamagishi S(2014)S100/Calgranulin-mediated inflammation accelerates left ventricular hypertrophy and aortic valve sclerosis in chronic kidney disease in a receptor for advanced glycation end products-dependent manner Arterioscler Thromb Vasc Biol 10 241-247
[8]  
Ueda S(2009)The inflammasome: a caspase-1-activation platform that regulates immune responses and disease pathogenesis Nat Immunol 20 319-325
[9]  
Nakamura K(2004)NALP3 forms an IL-1beta-processing inflammasome with increased activity in Muckle-Wells autoinflammatory disorder Immunity 175 7611-7622
[10]  
Imaizumi T(2005)Potentiation of caspase-1 activation by the P2 × 7 receptor is dependent on TLR signals and requires NF-kappaB-driven protein synthesis J Immunol 275 206-209